Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-751 in Refractory Colorectal Carcinoma
NCT00073138Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abt-751 in colorectal cancer (CRC), sponsored by Abbott Laboratories. Started Aug 2003; status: completed.
02
Drugs
abt-751
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00073138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073138.